Zutphen, The Netherlands - 26 February 2016
ESPERITE N.V. (Euronext: ESP, 'ESPERITE', or 'the Group') announces that following the amendment of the Dutch Financial Supervision Act (FSA) as a result of the implementation of the (amended) European Union's so-called Transparency Directive, the Company is required to disclose its home Member State. In accordance with FSA Section 5:25a, the Company herewith announces that its home Member State is the Netherlands.
About ESPERITE
ESPERITE Group, listed at Euronext Amsterdam and Paris, is a leading international company in regenerative and predictive medicine established in 2000.
To learn more about ESPERITE Group, or to book an interview with CEO Frédéric Amar: +31 575 548 998 - ir@esperite.com or visit the websites at www.esperite.com and www.genoma.com.
